Mach, F. Et Al. 2019. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. ATHEROSCLEROSIS , vol.290 , 140-205.

Mach, F., Baigent, C., Catapano, A. L., Koskina, K. C., Casula, M., Badimon, L., ... Chapman, M. J.(2019). 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. ATHEROSCLEROSIS , vol.290, 140-205.

Mach, Francois Et Al. "2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk," ATHEROSCLEROSIS , vol.290, 140-205, 2019

Mach, Francois Et Al. "2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk." ATHEROSCLEROSIS , vol.290, pp.140-205, 2019

Mach, F. Et Al. (2019) . "2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk." ATHEROSCLEROSIS , vol.290, pp.140-205.

@article{article, author={Francois Mach Et Al. }, title={2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk}, journal={ATHEROSCLEROSIS}, year=2019, pages={140-205} }